📂 Drugs
tisagenlecleucel — Definition
tisagenlekleusel / tisagenlecleucel
Tisagenlecleucel is a kind of genetic engineering product kimera antigen receptor (CAR) T cell therapy. This treatment is prepared with the modified of CD19 antigen in the laboratory environment by collecting the patient’s own T cells. Specifically used in B cell-source cancers such as relapses or refractory acute lymphoblastic leukemia (ALL) and diffuse large B cell lymphoma (DLBCL). The modified T cells after infusion destroy cancer cells by recognizing and can cause serious side effects such as cytokin oscillation syndrome.
Frequently Asked Questions
❓ What is tisagenlekleusel?
tisagenlekleusel; tisagenlecleucel is a kind of genetic engineering product kimera antigen receptor (CAR) T cell therapy. This treatment is prepared with the modified of CD19 antigen in the laboratory environment by collecting the patient’s own T cells. Specifically used in B cell-source cancers such as relapses or refractory acute lymphoblastic leukemia (ALL) and diffuse large B cell lymphoma (DLBCL). The modified T cells after infusion destroy cancer cells by recognizing and can cause serious side effects such as cytokin oscillation syndrome.
❓ What is tisagenlecleucel in Turkish?
The Turkish equivalent of "tisagenlecleucel" is tisagenlekleusel.
❓ Which medical field is tisagenlekleusel related to?
This term belongs to the Drugs category.